# Evaluation of CRB in PROM Patients

> **NCT01736852** · NA · COMPLETED · sponsor: **Cook Group Incorporated** · enrollment: 129 (actual)

## Conditions studied

- Premature Rupture of Fetal Membranes

## Interventions

- **DEVICE:** CRB
- **DRUG:** Pitocin

## Key facts

- **NCT ID:** NCT01736852
- **Lead sponsor:** Cook Group Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736852, "Evaluation of CRB in PROM Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01736852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*